Consolidated Balance Sheets - USD ($) $ in Thousands		Mar. 31, 2024		Dec. 31, 2023
Assets
Cash and cash equivalents		$ 54,778		$ 52,591
Federal funds sold		114,347		97,254
Investment securities		53,038		54,282
Equity investments		16,374		11,430
Loans		2,228,426		2,215,886
Allowance for credit losses		(83,827)	[1]	(84,235)	[2]
Net loans receivable		2,144,599		2,131,651
Goodwill		150,803		150,803
Intangible assets, net		20,230		20,591
Property, equipment, and right-of-use lease asset, net		14,024		14,076
Accrued interest receivable		12,673		13,538
Loan collateral in process of foreclosure	[3]	10,198		11,772
Income tax receivable				671
Other assets		27,698		29,168
Total assets		2,618,762		2,587,827
Liabilities
Deposits	[4]	1,879,061		1,866,657
Long-term debt	[5]	225,558		235,544
Short-term borrowings		32,500		8,000
Deferred tax liabilities, net		24,846		21,207
Operating lease liabilities		6,710		7,019
Accrued interest payable		6,077		6,822
Income tax payable		1,980
Accounts payable and accrued expenses	[6]	24,206		30,804
Total liabilities		2,200,938		2,176,053
Commitments and contingencies
Stockholders’ equity
Preferred stock (1,000,000 shares of $0.01 par value stock authorized-none outstanding)		0		0
Common stock (50,000,000 shares of $0.01 par value stock authorized - 29,243,878 shares at March 31, 2024 and 29,051,800 shares at December 31, 2023 issued)		292		291
Additional paid in capital		288,685		288,046
Treasury stock (5,866,314 shares at March 31, 2024 and 5,602,154 at December 31, 2023)		(47,664)		(45,538)
Accumulated other comprehensive loss		(3,846)		(3,696)
Retained earnings		111,569		103,883
Total stockholders’ equity		349,036		342,986
Non-controlling interest in consolidated subsidiaries		68,788		68,788
Total equity		417,824		411,774
Total liabilities and equity		$ 2,618,762		$ 2,587,827
Number of shares outstanding		23,377,564		23,449,646
Book value per share		$ 14.93		$ 14.63

[1] As of March 31, 2024 and March 31, 2023, there were no allowance for credit losses and net charge-offs related to the strategic partnership loans.

[2] 2023 beginning balance represents allowance prior to the adoption of ASU 2016-13.

[3] Includes financed sales of this collateral to third parties that are reported separately from the loan portfolio, of $5.8 million as of March 31, 2024 and $6.2 million as of December 31, 2023.

[4] Includes $4.3 million of deferred financing costs as of both March 31, 2024 and December 31, 2023. Refer to Note 5 for more details.

[5] Includes $4.2 million of deferred financing costs as of both March 31, 2024 and December 31, 2023. Refer to Note 5 for more details.

[6] Includes the short-term portion of lease liabilities of $2.3 million and $2.5 million as of March 31, 2024 and December 31, 2023. Refer to Note 6 for more details.